PI3K / Akt Signaling
| CSTコード |
包装 |
希望納入価格 (円) |
国内在庫  |
ご登録代理店情報  カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #2965S | 100 μL | 57,000 | |
|
| #2965L | 300 μL | 137,000 | |
| #2965P | 40 μL for Custom Sampler Kit |  Custom Antibody Sampler Kitの構成品を選択できます。
5本以上を選択し、ページ右上のCartから製品確定書を発行してください。
尚、構成品の単品販売は致しておりません。 | |
シグナル伝達研究応援キャンペーン プレゼント *Pサイズのみ
Akt抗体製品一覧
2965 の推奨プロトコール
最適な結果を得るために:Cell Signaling Technology (CST) 社は、各製品の推奨プロトコールを使用することを強くお薦めいたします。
推奨プロトコールはCST社内試験の徹底的なバリデーションに基づいて作成されておりますので、正確かつ再現性の高い結果が得られます。
注:各製品に最適化されたプロトコールをリンクしています。
| | |
-
2965:
-
Flow
Immunofluorescence
Western Blotting
| 用途(希釈倍率) | |
| ウェスタンブロッティング(1:1,000)、免疫蛍光細胞染色(IF-IC)(1:800)、フローサイトメトリー(1:100) |
| 種交差性 | |
| ヒト、マウス 、ラット 、サル、ハムスター |
| 特異性・感度 | |
| 内在性レベルのThr308 がリン酸化されたAkt タンパク質を検出します。 |
| 使用抗原 | |
| マウスのAkt タンパク質のThr308 周辺領域(合成リン酸化ペプチド) |
Western Blotting

Western blot analysis of extracts from NIH/3T3 and Jurkat cells, untreated, PDGF-treated or LY294002-treated as indicated, using Phospho-Akt (Thr308) (C31E5E) Rabbit mAb (upper) or Akt (pan) (C67E7) Rabbit mAb #4691 (lower).
Flow Cytometry

Flow cytometric analysis of Jurkat cells, untreated (green) or LY294002, Wortmannin and U0126-treated (blue), using Phospho-Akt (Thr308) (C31E5E) Rabbit mAb.
IF-IC

Confocal immunofluorescent analysis of C2C12 cells, insulin-treated (left) or LY294002-treated (right), using Phospho-Akt (Thr308) (C31E5E) Rabbit mAb (green). Actin filaments have been labeled with Alexa Fluor® 555 phalloidin (red). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).
Akt, also referred to as PKB or Rac, plays a critical role in controlling survival and apoptosis (1-3). This protein kinase is activated by insulin and various growth and survival factors to function in a wortmannin-sensitive pathway involving PI3 kinase (2,3). Akt is activated by phospholipid binding and activation loop phosphorylation at Thr308 by PDK1 (4) and by phosphorylation within the carboxy terminus at Ser473. The previously elusive PDK2 responsible for phosphorylation of Akt at Ser473 has been identified as mammalian target of rapamycin (mTOR) in a rapamycin-insensitive complex with rictor and Sin1 (5,6). Akt promotes cell survival by inhibiting apoptosis through phosphorylation and inactivation of several targets, including Bad (7), forkhead transcription factors (8), c-Raf (9), and caspase-9. PTEN phosphatase is a major negative regulator of the PI3 kinase/Akt signaling pathway (10). LY294002 is a specific PI3 kinase inhibitor (11). Another essential Akt function is the regulation of glycogen synthesis through phosphorylation and inactivation of GSK-3α and β (12,13). Akt may also play a role in insulin stimulation of glucose transport (12). In addition to its role in survival and glycogen synthesis, Akt is involved in cell cycle regulation by preventing GSK-3β-mediated phosphorylation and degradation of cyclin D1 (14) and by negatively regulating the cyclin dependent kinase inhibitors p27 Kip (15) and p21 Waf1/CIP1 (16). Akt also plays a critical role in cell growth by directly phosphorylating mTOR in a rapamycin-sensitive complex containing raptor (17). More importantly, Akt phosphorylates and inactivates tuberin (TSC2), an inhibitor of mTOR within the mTOR-raptor complex (18,19).
-
Franke, T.F. et al. (1997) Cell 88, 435-7.
-
Burgering, B.M. and Coffer, P.J. (1995) Nature 376, 599-602.
-
Franke, T.F. et al. (1995) Cell 81, 727-36.
-
Alessi, D.R. et al. (1996) EMBO J 15, 6541-51.
-
Sarbassov, D.D. et al. (2005) Science 307, 1098-101.
-
Jacinto, E. et al. (2006) Cell 127, 125-37.
-
Cardone, M.H. et al. (1998) Science 282, 1318-21.
-
Brunet, A. et al. (1999) Cell 96, 857-68.
-
Zimmermann, S. and Moelling, K. (1999) Science 286, 1741-4.
-
Cantley, L.C. and Neel, B.G. (1999) Proc Natl Acad Sci USA 96, 4240-5.
-
Vlahos, C.J. et al. (1994) J Biol Chem 269, 5241-8.
-
Hajduch, E. et al. (2001) FEBS Lett 492, 199-203.
-
Cross, D.A. et al. (1995) Nature 378, 785-9.
-
Diehl, J.A. et al. (1998) Genes Dev 12, 3499-511.
-
Gesbert, F. et al. (2000) J Biol Chem 275, 39223-30.
-
Zhou, B.P. et al. (2001) Nat Cell Biol 3, 245-52.
-
Navé, B.T. et al. (1999) Biochem J 344 Pt 2, 427-31.
-
Inoki, K. et al. (2002) Nat Cell Biol 4, 648-57.
-
Manning, B.D. et al. (2002) Mol Cell 10, 151-62.